Clinical characteristics related to methotrexate-induced pancytopenia.
Ohosone
Y
Y
Okano
Y
Y
Kameda
H
H
Hama
N
N
Mimori
T
T
Akizuki
M
M
Ikeda
Y
Y
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010198:Pancytopenia / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors
D018501:Antirheumatic Agents; D008727:Methotrexate